by adminTorusBrand | Feb 15, 2017 | HempMeds Brasil, Press Releases, Scientific Research
Article details the groundbreaking decision and possible implications for Alzheimer’s patients SAN DIEGO, Feb. 15, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded Cannabis Company in the United States, subsidiary HempMeds®...
by adminTorusBrand | Feb 15, 2017 | HempMeds Brasil, Press Releases, Scientific Research
Article details the groundbreaking decision and possible implications for Alzheimer’s patients SAN DIEGO, Feb. 15, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded Cannabis Company in the United States, subsidiary HempMeds®...
by adminTorusBrand | Feb 14, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Media Coverage
Medical Marijuana, Inc. VP of Operations Blake Schroeder and Andrew Hard, CEO of CMW Media, sat down with Drew Schlosberg of the San Diego Union-Tribune Community Spotlight late last week to discuss the cannabis industry and Medical Marijuana, Inc.’s role as a proven...
by adminTorusBrand | Feb 14, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Media Coverage
Medical Marijuana, Inc. VP of Operations Blake Schroeder and Andrew Hard, CEO of CMW Media, sat down with Drew Schlosberg of the San Diego Union-Tribune Community Spotlight late last week to discuss the cannabis industry and Medical Marijuana, Inc.’s role as a proven...
by adminTorusBrand | Feb 8, 2017 | Company News, HempMeds Brasil, Scientific Research
The Brazilian health authority has approved the importation of HempMeds® CBD hemp oil product RSHO™ for patient diagnosed with Alzheimer’s disease. HempMeds® Brasil, a Medical Marijuana, Inc. portfolio company and the local distribution branch for Medical Marijuana,...